Details for New Drug Application (NDA): 213827
✉ Email this page to a colleague
The generic ingredient in METOLAZONE is metolazone. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the metolazone profile page.
Summary for 213827
Tradename: | METOLAZONE |
Applicant: | Innogenix |
Ingredient: | metolazone |
Patents: | 0 |
Pharmacology for NDA: 213827
Physiological Effect | Increased Diuresis |
Medical Subject Heading (MeSH) Categories for 213827
Suppliers and Packaging for NDA: 213827
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
METOLAZONE | metolazone | TABLET;ORAL | 213827 | ANDA | Major Pharmaceuticals | 0904-7328 | 0904-7328-61 | 100 BLISTER PACK in 1 CARTON (0904-7328-61) / 1 TABLET in 1 BLISTER PACK |
METOLAZONE | metolazone | TABLET;ORAL | 213827 | ANDA | Major Pharmaceuticals | 0904-7329 | 0904-7329-61 | 100 BLISTER PACK in 1 CARTON (0904-7329-61) / 1 TABLET in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | Mar 30, 2021 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Mar 30, 2021 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Mar 30, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription